SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Month: February 2016

    National Eye Institute Receives Funding Increase

    Posted on February 28, 2016 by droberts
  • February 28, 2016

    National Eye Institute Receives Funding Increase

    Representatives from Prevent Blindness travel annually to Washington D.C. to advocate for Congressional support of programs and research for the visually impaired. The time spent on Capitol Hill has paid off this year with passage of the Consolidated Appropriations Act of 2016, signed by President Obama in December. Funding has taken some hard hits over […]

      Also posted in
    • Latest News
  • Large Study Shows 1 in 5 People With Vision Loss Experience Hallucinations

    Posted on February 27, 2016January 3, 2021 by droberts
  • February 27, 2016

    Large Study Shows 1 in 5 People With Vision Loss Experience Hallucinations

    A new study conducted by the Canadian National Institute for the Blind (CNIB) has found that one in five Canadians with vision loss who were surveyed experience visual hallucinations, known as Charles Bonnet Syndrome (CBS). The study, titled “Prevalence of visual hallucinations in a national low vision client population”, published in the most recent issue […]

      Also posted in
    • Eye Conditions
    • Latest News
  • Future Sustained Drug Delivery Methods for Choroidal Neovascularization

    Posted on February 27, 2016 by droberts
  • February 27, 2016

    Future Sustained Drug Delivery Methods for Choroidal Neovascularization

    During the American Academy of Ophthalmology’s Retina Subspecialty Day in 2015, Peter K. Kaiser, MD, described six alternative methods being looked at for delivery of anti-VEGF drugs into the retinas of individuals experiencing choroidal neovascularization (CNV). Periodic intraocular injections are currently the only procedure for halting damaging blood vessel growth and leakage. Injections are expensive, time-consuming, and burdensome on the patients, so […]

      Also posted in
    • Latest News
    • Research and Developments
  • Low Vision Rehabilitation Needs More Emphasis on Communication and Social Skills

    Posted on February 27, 2016 by droberts
  • February 27, 2016

    Low Vision Rehabilitation Needs More Emphasis on Communication and Social Skills

    Lea Hyvärinen, MD, PhD (Honorary Professor, Rehabilitation Sciences at Rehabilitation and Education in Blindness or Impairment of Vision in Dortmund, Germany) has described social difficulties caused by types of blindness and visual impairment. In her paper, “Effect of Vision Loss on Communication and Social Skills” she writes that “many problems in communication and social skills are due to misunderstandings […]

      Also posted in
    • Daily Living
    • Low Vision Rehabilitation
  • New Combination Therapy Treats Retinal Damage in Diabetics

    Posted on February 15, 2016 by droberts
  • February 15, 2016

    New Combination Therapy Treats Retinal Damage in Diabetics

    Aerpio Therapeutics, Inc. has announced promising results from their “TIME-2” study of  AKB-9778 as a treatment for diabetic retinopathy (DR). AKB-9778 alone and in combination with Lucentis® (ranibizumab) improved underlying retinopathy by 10.0%, and 11.4% compared to 8.8% of patients receiving Lucentis® alone. The clinical findings were presented by Pravin U. Dugel, M.D., at the […]

      Also posted in
    • Latest News
    • Research and Developments
  • AVA-101 May Extend Time Between Wet AMD Treatments

    Posted on February 10, 2016May 30, 2020 by droberts
  • February 10, 2016

    AVA-101 May Extend Time Between Wet AMD Treatments

    In 2014, Avalanche Biotechnologies postulated that a single injection of a new gene therapy treatment could possibly stop blood vessel growth and leakage in the wet form of Age-Related Macular Degeneration (AMD) for several years. A single injection of a drug called AVA-101 (aka sFlt-1) could create a kind of biofactory that continuously secretes a therapeutic protein […]

      Also posted in
    • Latest News
    • Research and Developments
  • High Dose Statins May Be Effective In Treating Dry AMD

    Posted on February 5, 2016 by droberts
  • February 5, 2016

    High Dose Statins May Be Effective In Treating Dry AMD

    Researchers at Massachusetts Eye and Ear/Harvard Medical School and the University of Crete have found that high doses of statins (cholesterol-lowering medications) can effectively reduce the number of soft drusen deposits in retinas of people with dry age-related macular degeneration (dAMD). The findings from their phase I/II clinical trial were published in the recent issue of […]

      Also posted in
    • Latest News
    • Research and Developments
  • Accessible Driving Is On The Horizon

    Posted on February 3, 2016January 12, 2019 by droberts
  • February 3, 2016

    Accessible Driving Is On The Horizon

    by Dan Roberts A couple of changes are on the horizon which may allow visually impaired people to regain or maintain the pleasure of piloting their own private vehicles whenever and wherever they choose. The most immediate change could come from relaxation of the minimum visual acuity requirements, made possible in part by the development of bioptic […]

      Also posted in
    • Latest News
    • Research and Developments
  • Bausch + Lomb Partners with Prevent Blindness® to Urge Americans to Fight for Their Sight 

    Posted on February 3, 2016 by droberts
  • February 3, 2016

    Bausch + Lomb Partners with Prevent Blindness® to Urge Americans to Fight for Their Sight 

    February is Age-related Macular Degeneration Awareness (AMD) Month From Valentine’s Day to American Heart Health Month, February is traditionally the most heart-driven month of the year. This February, Bausch + Lomb is partnering with Prevent Blindness®, the nation’s oldest volunteer eye health and safety organization, dedicated to fighting blindness and saving sight, to encourage the […]

      Also posted in
    • Latest News
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.